A Study to Analyze the Effects of Exparel for Post-Surgery Pain Control in Patients Undergoing Penile Prosthesis Placement

Sponsor
Mayo Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT04801368
Collaborator
(none)
130
1
2
19
6.9

Study Details

Study Description

Brief Summary

The purpose of this research is to determine the effects of penile ring block for local anesthesia with liposomal bupivacaine vs ropivacaine mixture in subjects undergoing surgery for Penile Prosthesis Placement.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Randomization of two local anesthetics.
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The two anesthetics being used in the study are FDA approved and used in standard practice for the procedure.The two anesthetics being used in the study are FDA approved and used in standard practice for the procedure.
Masking:
Single (Participant)
Masking Description:
Patient is blind to local anesthetic being administered.
Primary Purpose:
Basic Science
Official Title:
A Randomized-Controlled Trial Comparing Long-acting and Short-acting Local Anesthetics at the Time of Penile Prosthesis Placement
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Receiving Ropivacaine

Patients receiving Ropivacaine.

Procedure: Randomization of two local anesthetics.
Patients will be blinded and randomized to two different arms. One receiving ropivacaine, one receiving liposomal bupivacaine.

Experimental: Receiving Liposomal Bupivacaine

Patients receiving Liposomal Bupivacaine.

Procedure: Randomization of two local anesthetics.
Patients will be blinded and randomized to two different arms. One receiving ropivacaine, one receiving liposomal bupivacaine.

Outcome Measures

Primary Outcome Measures

  1. Visual-analogue pain scale [post-operative day 1]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.

  2. Visual-analogue pain scale [post-operative day 3]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.

  3. Visual-analogue pain scale [post-operative day 7]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.

  4. Visual-analogue pain scale [post-operative day 14]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.

  5. Visual-analogue anxiety scale [post-operative day 1]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.

  6. Visual-analogue anxiety scale [post-operative day 3]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.

  7. Visual-analogue anxiety scale [post-operative day 7]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.

  8. Visual-analogue anxiety scale [post-operative day 14]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.

  9. State Trait Anxiety Inventory [post-operative day 1]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.

  10. State Trait Anxiety Inventory [post-operative day 3]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.

  11. State Trait Anxiety Inventory [post-operative day 7]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.

  12. State Trait Anxiety Inventory [post-operative day 14]

    Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.

  13. Pain Catastrophizing scale [post-operative day 1]

    Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.

  14. Pain Catastrophizing scale [post-operative day 3]

    Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.

  15. Pain Catastrophizing scale [post-operative day 7]

    Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.

  16. Pain Catastrophizing scale [post-operative day 14]

    Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men undergoing 3-piece penile prosthesis placement under general anesthesia at Mayo Clinic - Rochester.

  • ≥ 18 years old.

Exclusion Citeria:
  • History of opioid exposure within the preceding 90 days prior to surgery (based on patient-report, review of the electronic medical record, and NMP prescribing database review)

  • Current or prior history of alcohol or drug abuse (illicit or prescription)

  • History of chronic pain conditions (chronic musculoskeletal pain, fibromyalgia, central sensitization, chronic pelvic pain syndrome, etc.)

  • History of cardiac arrhythmia or untreated severe cardiovascular disease

  • Uncontrolled hypertension

  • Hepatic insufficiency

  • Renal insufficiency (CKD stage IIIa or greater)

  • Current anti-platelet or anti-coagulation therapy with plans to continue at the time of prosthesis placement

  • Poorly controlled diabetes mellitus (defined as HgbA1c > 8.5 within 30 days of surgery)

  • Concurrent adjunctive operative procedures planned at the time of penile prosthesis placement (examples: male urethral sling, Peyronie's disease straightening with penile plication or incision/grafting)

  • Concurrent non-prosthetic surgery planned at the time of penile prosthesis placement (examples: circumcision, hernia repair, hydrocelectomy, etc.)

  • Planned infrapubic or subcoronal incision at the time of penile prosthesis placement

  • Patients who will be undergoing prosthesis placement using local, monitored, or spinal anesthesia (i.e. non-general anesthesia)

  • Allergy or history of intolerance to any local anesthetic agents included in the protocol

  • History of prior penile prosthesis or artificial urinary sphincter surgery

  • Revision penile prosthesis surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic in Rochester Rochester Minnesota United States 55905

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Matthew J Ziegelmann, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Matthew (Matt) J. Ziegelmann, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT04801368
Other Study ID Numbers:
  • 20-010842
First Posted:
Mar 17, 2021
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2022